At the news
? NEUTRALIMPACT 5/10 PRESS-RELEASE filed Mar 25, 2026 at 16:05 ET
Outlook Therapeutics (OTLK) closed a public offering of 20 million shares and accompanying warrants to purchase 20 million shares at $0.25 per unit, raising $5.0 million in gross proceeds. The warrants are exercisable immediately at $0.25 per share and expire in five years, with potential for an additional $5.0 million in proceeds if fully exercised. Proceeds will be used for working capital and general corporate purposes.
- Closed public offering of 20,000,000 shares and 20,000,000 warrants at $0.25 per unit
- Aggregate gross proceeds of $5.0 million
- Warrants exercisable immediately at $0.25 per share, five-year term
- Potential additional $5.0 million in gross proceeds if warrants are fully exercised
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access